• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘内注射强啡肽A1-13和强啡肽A3-13通过非阿片类机制降低大鼠脊髓血流量。

Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.

作者信息

Long J B, Kinney R C, Malcolm D S, Graeber G M, Holaday J W

机构信息

Department of Medical Neurosciences, Walter Reed Army Institute of Research, Washington, DC 20307-5100.

出版信息

Brain Res. 1987 Dec 15;436(2):374-9. doi: 10.1016/0006-8993(87)91683-0.

DOI:10.1016/0006-8993(87)91683-0
PMID:2893653
Abstract

Radiolabeled microspheres were used to examine the effects of paralytic intrathecal doses of dynorphin A (Dyn A1-13) and Dyn A3-13 on rat brain and spinal cord blood flows and cardiac output. Dyn A1-13 produced significant dose-related reductions in blood flow to lumbosacral and thoracic spinal cord without altering cardiac output and blood flow to brain and cervical spinal cord. Naloxone failed to block these effects. Dyn A3-13, which lacks opioid activity, also significantly reduced blood flow in lumbosacral spinal cord. Thus, the paralytic effects of Dyn A in the rat may involve reductions in spinal cord resulting from non-opioid actions of Dyn A.

摘要

放射性标记微球被用于检测鞘内注射麻痹剂量的强啡肽A(Dyn A1-13)和Dyn A3-13对大鼠脑、脊髓血流及心输出量的影响。Dyn A1-13使腰骶部和胸段脊髓血流显著减少,且呈剂量相关性,同时不改变心输出量以及脑和颈段脊髓的血流。纳洛酮未能阻断这些效应。缺乏阿片样活性的Dyn A3-13也显著降低了腰骶部脊髓的血流。因此,强啡肽A在大鼠体内的麻痹作用可能涉及由其非阿片样作用导致的脊髓血流减少。

相似文献

1
Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.鞘内注射强啡肽A1-13和强啡肽A3-13通过非阿片类机制降低大鼠脊髓血流量。
Brain Res. 1987 Dec 15;436(2):374-9. doi: 10.1016/0006-8993(87)91683-0.
2
Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.鞘内注射强啡肽A(1-13)和(3-13)通过非阿片类机制减少脊髓血流量。
NIDA Res Monogr. 1986;75:524-6.
3
Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
J Pharmacol Exp Ther. 1988 Sep;246(3):1167-74.
4
Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
J Pharmacol Exp Ther. 1988 Sep;246(3):1158-66.
5
Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
Brain Res. 1991 Nov 22;565(1):67-77. doi: 10.1016/0006-8993(91)91737-l.
6
Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.阿片类和非阿片类机制可能在脊髓损伤中对强啡肽的病理生理作用有所贡献。
Ann Neurol. 1990 Jan;27(1):67-74. doi: 10.1002/ana.410270111.
7
Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.选择性和非选择性κ-阿片受体激动剂对大鼠背角神经元皮肤C纤维诱发反应的影响。
Brain Res. 1987 Jul 7;415(1):21-9. doi: 10.1016/0006-8993(87)90265-4.
8
Endogenous opioids in spinal cord injury: a critical evaluation.脊髓损伤中的内源性阿片类物质:一项批判性评估。
Cent Nerv Syst Trauma. 1986 Fall;3(4):295-315. doi: 10.1089/cns.1986.3.295.
9
Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
Peptides. 1985 Nov-Dec;6(6):1015-20. doi: 10.1016/0196-9781(85)90423-1.
10
Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.精氨酸加压素8在大鼠脊髓蛛网膜下腔注射后会减少脊髓血流量。
J Pharmacol Exp Ther. 1989 May;249(2):499-506.

引用本文的文献

1
Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.SARS-CoV-2 诱导的 ACE2 失调在 COVID-19 严重程度中起着关键作用。
Biomed Pharmacother. 2021 May;137:111363. doi: 10.1016/j.biopha.2021.111363. Epub 2021 Feb 5.
2
Current and future medical therapeutic strategies for the functional repair of spinal cord injury.脊髓损伤功能修复的当前及未来医学治疗策略
World J Orthop. 2015 Jan 18;6(1):42-55. doi: 10.5312/wjo.v6.i1.42.
3
Opioid administration following spinal cord injury: implications for pain and locomotor recovery.
脊髓损伤后阿片类药物的应用:对疼痛和运动功能恢复的影响。
Exp Neurol. 2013 Sep;247:328-41. doi: 10.1016/j.expneurol.2013.03.008. Epub 2013 Mar 15.
4
Pathobiology of dynorphins in trauma and disease.强啡肽在创伤和疾病中的病理生物学
Front Biosci. 2005 Jan 1;10:216-35. doi: 10.2741/1522.
5
A direct chemical interaction between dynorphin and excitatory amino acids.强啡肽与兴奋性氨基酸之间的直接化学相互作用。
Neurochem Res. 2001 Apr;26(4):395-400. doi: 10.1023/a:1010903215566.
6
Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.强啡肽A(1-13)的体外神经毒性:小鼠脊髓神经元中的阿片类和非阿片类机制
Exp Neurol. 1999 Dec;160(2):361-75. doi: 10.1006/exnr.1999.7235.
7
Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.强啡肽A及相关肽的中枢非阿片类生理和病理生理作用。
J Psychiatry Neurosci. 1992 Sep;17(3):106-19.